GS0421: Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders
Case File Event Statements
11/21/2023 - 2 years ago
44 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
11/21/2023 - 2 years ago
43 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDType:MAB2
11/21/2023 - 2 years ago
42 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
8/7/2023 - 2 years ago
41 - NOTIFICATION OF FINAL REFUSAL EMAILEDType:GNFN
8/7/2023 - 2 years ago
40 - FINAL REFUSAL E-MAILEDType:GNFR
8/7/2023 - 2 years ago
39 - SU - FINAL REFUSAL - WRITTENType:CNFR
7/10/2023 - 2 years ago
38 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
7/10/2023 - 2 years ago
37 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
7/10/2023 - 2 years ago
36 - ASSIGNED TO LIEType:ALIE
3/9/2023 - 2 years ago
35 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
1/3/2023 - 2 years ago
34 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
1/3/2023 - 2 years ago
33 - NON-FINAL ACTION E-MAILEDType:GNRT
1/3/2023 - 2 years ago
32 - SU - NON-FINAL ACTION - WRITTENType:CNRT
11/4/2022 - 3 years ago
31 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
10/20/2022 - 3 years ago
30 - USE AMENDMENT FILEDType:IUAF
11/3/2022 - 3 years ago
29 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU